HCM
ABBV icon

HM Capital Management’s AbbVie ABBV Stock Holding History

HM Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,378
Closed -$211K – 57
2022
Q2 		$211K Hold
1,378
– – 0.12% 54
2022
Q1 		$223K Buy
+1,378
New +$200K 0.08% 54
2020
Q3 		– Sell
-5,351
Closed -$525K – 37
2020
Q2 		$525K Buy
+5,351
New +$471K 0.34% 21

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HM Capital Management's ABBV Position: Q3 2022 in Review

HM Capital Management sold out of AbbVie (ABBV) in Q3 2022, closing a stake of 1,378 shares — an estimated $211K sold.

HM Capital Management first reported a position in ABBV in Q2 2020 and held it in 3 quarters. The position peaked at $525K in Q2 2020. 2,971 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • HM Capital Management reported no remaining AbbVie position as of Q3 2022 after selling out during the quarter.
  • HM Capital Management sold 1,378 AbbVie shares in Q3 2022, an estimated $211K.
  • HM Capital Management first reported a position in AbbVie in Q2 2020 and held it in 3 quarters.
  • HM Capital Management's AbbVie position peaked at $525K in Q2 2020.
  • 2,971 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on HM Capital Management's 13F filing for Q3 2022, filed 7 Nov 2022.